Management of systemic lupus erythematosus in pregnancy

Systemic lupus erythematosus is one of the most common autoimmune disorders affecting young women. Pregnant women with lupus are generally at higher risk for certain pregnancy complications than women without comorbidities. Even so, a pregnancy with lupus can be carried to term in optimal conditions...

Full description

Bibliographic Details
Main Authors: Oana Denisa Bălălău, Mihai George Loghin, Delia Maria Bogheanu, Nicolae Bacalbasa, Anca Daniela Stănescu, Daniela Gabriela Bălan, Ioana Păunică, Octavian Gabriel Olaru
Format: Article
Language:English
Published: Ion Motofei, Carol Davila University 2022-10-01
Series:Journal of Mind and Medical Sciences
Subjects:
Online Access:https://scholar.valpo.edu/cgi/viewcontent.cgi?article=1358&context=jmms
_version_ 1811234361856491520
author Oana Denisa Bălălău
Mihai George Loghin
Delia Maria Bogheanu
Nicolae Bacalbasa
Anca Daniela Stănescu
Daniela Gabriela Bălan
Ioana Păunică
Octavian Gabriel Olaru
author_facet Oana Denisa Bălălău
Mihai George Loghin
Delia Maria Bogheanu
Nicolae Bacalbasa
Anca Daniela Stănescu
Daniela Gabriela Bălan
Ioana Păunică
Octavian Gabriel Olaru
author_sort Oana Denisa Bălălău
collection DOAJ
description Systemic lupus erythematosus is one of the most common autoimmune disorders affecting young women. Pregnant women with lupus are generally at higher risk for certain pregnancy complications than women without comorbidities. Even so, a pregnancy with lupus can be carried to term in optimal conditions if it is properly managed by a doctor. Monitoring is generally recommended six months after the onset of lupus symptoms, and ideally there should be no active lupus symptoms prior to conception. General screening tests should include the anti-phospholipid, anti-Ro and anti-La antibodies. Women who are positive for these antibodies have an increased risk of congenital heart block in the fetus. In addition, pregnant women with lupus have an increased risk of spontaneous abortion, intrauterine fetal growth restriction, pre-term birth, while neonatal lupus syndrome is a major fetal condition. The maternal risks are faced with disease flares, pre-eclampsia and other complications. Treatment options during pregnancy are limited to a few safe medications. For example, prednisone is unlikely to cause fetal malformations, but it increases the risk of diabetes and high blood pressure in the mother. Consequently, a careful multidisciplinary monitoring is essential for optimal results in pregnancy with lupus.
first_indexed 2024-04-12T11:36:27Z
format Article
id doaj.art-8448e9bc779b4a63a1c508b81ea0daf6
institution Directory Open Access Journal
issn 2392-7674
language English
last_indexed 2024-04-12T11:36:27Z
publishDate 2022-10-01
publisher Ion Motofei, Carol Davila University
record_format Article
series Journal of Mind and Medical Sciences
spelling doaj.art-8448e9bc779b4a63a1c508b81ea0daf62022-12-22T03:34:50ZengIon Motofei, Carol Davila UniversityJournal of Mind and Medical Sciences2392-76742022-10-019223624110.22543/2392-7674.1358Management of systemic lupus erythematosus in pregnancyOana Denisa Bălălău0Mihai George Loghin1Delia Maria Bogheanu2Nicolae Bacalbasa3Anca Daniela Stănescu4Daniela Gabriela Bălan5Ioana Păunică6Octavian Gabriel Olaru7CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY, BUCHAREST, ROMANIACAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY, BUCHAREST, ROMANIABUCUR MATERNITY, ST. JOHN EMERGENCY CLINICAL HOSPITAL, BUCHAREST, ROMANIACAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY, BUCHAREST, ROMANIACAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY, BUCHAREST, ROMANIACAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY, DEPARTMENT OF PHYSIOLOGY, BUCHAREST, ROMANIACAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY, BUCHAREST, ROMANIACAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY, BUCHAREST, ROMANIASystemic lupus erythematosus is one of the most common autoimmune disorders affecting young women. Pregnant women with lupus are generally at higher risk for certain pregnancy complications than women without comorbidities. Even so, a pregnancy with lupus can be carried to term in optimal conditions if it is properly managed by a doctor. Monitoring is generally recommended six months after the onset of lupus symptoms, and ideally there should be no active lupus symptoms prior to conception. General screening tests should include the anti-phospholipid, anti-Ro and anti-La antibodies. Women who are positive for these antibodies have an increased risk of congenital heart block in the fetus. In addition, pregnant women with lupus have an increased risk of spontaneous abortion, intrauterine fetal growth restriction, pre-term birth, while neonatal lupus syndrome is a major fetal condition. The maternal risks are faced with disease flares, pre-eclampsia and other complications. Treatment options during pregnancy are limited to a few safe medications. For example, prednisone is unlikely to cause fetal malformations, but it increases the risk of diabetes and high blood pressure in the mother. Consequently, a careful multidisciplinary monitoring is essential for optimal results in pregnancy with lupus.https://scholar.valpo.edu/cgi/viewcontent.cgi?article=1358&context=jmmspregnancysystemic lupus erythematosusantiphospholipid antibodiesautoimmune disease
spellingShingle Oana Denisa Bălălău
Mihai George Loghin
Delia Maria Bogheanu
Nicolae Bacalbasa
Anca Daniela Stănescu
Daniela Gabriela Bălan
Ioana Păunică
Octavian Gabriel Olaru
Management of systemic lupus erythematosus in pregnancy
Journal of Mind and Medical Sciences
pregnancy
systemic lupus erythematosus
antiphospholipid antibodies
autoimmune disease
title Management of systemic lupus erythematosus in pregnancy
title_full Management of systemic lupus erythematosus in pregnancy
title_fullStr Management of systemic lupus erythematosus in pregnancy
title_full_unstemmed Management of systemic lupus erythematosus in pregnancy
title_short Management of systemic lupus erythematosus in pregnancy
title_sort management of systemic lupus erythematosus in pregnancy
topic pregnancy
systemic lupus erythematosus
antiphospholipid antibodies
autoimmune disease
url https://scholar.valpo.edu/cgi/viewcontent.cgi?article=1358&context=jmms
work_keys_str_mv AT oanadenisabalalau managementofsystemiclupuserythematosusinpregnancy
AT mihaigeorgeloghin managementofsystemiclupuserythematosusinpregnancy
AT deliamariabogheanu managementofsystemiclupuserythematosusinpregnancy
AT nicolaebacalbasa managementofsystemiclupuserythematosusinpregnancy
AT ancadanielastanescu managementofsystemiclupuserythematosusinpregnancy
AT danielagabrielabalan managementofsystemiclupuserythematosusinpregnancy
AT ioanapaunica managementofsystemiclupuserythematosusinpregnancy
AT octaviangabrielolaru managementofsystemiclupuserythematosusinpregnancy